CD274 and glioma: This study demonstrates that PD-L1 upregulation in gliomas and the glioma microenvironment is an important target; MLN4924, combined with blockade of the PD1/PD-L1 pathway, should be considered a potential candidate for glioma treatment strategy (Filippova et al., 2018).